GE HealthCare Technologies Inc.
For the period ended Dec 31, 2025. Filed Feb 4, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 4, 2026
GEHC$84.03+2.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Equity
| Consolidated Statements of Changes in Equity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Common stock · Treasury stock | ||||||||||
| (In millions, except per share amounts) | Shares | Amount | Shares | Amount | Additional paid-in capital | Retained earnings | Net parent investment | Accumulated other comprehensive income (loss) – net | Equity attributable to noncontrolling interests | Total equity |
| Balances as of December 31, 2022 | — | $— | — | $— | $— | $— | $11,235 | $(1,878) | $5 | $9,362 |
| Net transfers from GE, including Spin-Off-related adjustments | — | — | — | — | — | — | (4,851) | 2,000 | 2 | (2,849) |
| Issuance of common stock in connection with the Spin-Off and reclassification of net parent investment | 454 | 5 | — | — | 6,379 | — | (6,384) | — | — | — |
| Issuance of shares under equity awards, net of shares withheld for taxes and other | 1 | — | — | — | — | — | — | — | — | — |
| Net income attributable to GE HealthCare | — | — | — | — | — | 1,568 | — | — | — | 1,568 |
| Dividends declared ($0.12 per common share) | — | — | — | — | — | (55) | — | — | — | (55) |
| Other comprehensive income (loss) attributable to GE HealthCare | — | — | — | — | — | — | — | (813) | — | (813) |
| Changes in equity attributable to noncontrolling interests | — | — | — | — | — | — | — | — | 5 | 5 |
| Share-based compensation | — | — | — | — | 114 | — | — | — | — | 114 |
| Changes in equity due to redemption value adjustments on redeemable noncontrolling interests | — | — | — | — | — | (187) | — | — | — | (187) |
| Balances as of December 31, 2023 | 455 | 5 | — | — | 6,493 | 1,326 | — | (691) | 12 | 7,145 |
| Issuance of shares under equity awards, net of shares withheld for taxes and other | 2 | — | — | (25) | (35) | — | — | — | — | (60) |
| Net income attributable to GE HealthCare | — | — | — | — | — | 1,993 | — | — | — | 1,993 |
| Dividends declared ($0.125 per common share) | — | — | — | — | — | (58) | — | — | — | (58) |
| Other comprehensive income (loss) attributable to GE HealthCare | — | — | — | — | — | — | — | (688) | — | (688) |
| Changes in equity attributable to noncontrolling interests | — | — | — | — | — | — | — | — | 7 | 7 |
| Share-based compensation | — | — | — | — | 125 | — | — | — | — | 125 |
| Balances as of December 31, 2024 | 457 | 5 | — | (25) | 6,583 | 3,262 | — | (1,379) | 18 | 8,464 |
| Issuance of shares under equity awards, net of shares withheld for taxes and other | 2 | — | — | — | (5) | — | — | — | — | (5) |
| Repurchase of common stock | — | — | 3 | (200) | — | — | — | — | — | (200) |
| Net income attributable to GE HealthCare | — | — | — | — | — | 2,084 | — | — | — | 2,084 |
| Dividends declared ($0.14 per common share) | — | — | — | — | — | (64) | — | — | — | (64) |
| Other comprehensive income (loss) attributable to GE HealthCare | — | — | — | — | — | — | — | (9) | — | (9) |
| Changes in equity attributable to noncontrolling interests | — | — | — | — | — | — | — | — | (8) | (8) |
| Share-based compensation | — | — | — | — | 129 | — | — | — | — | 129 |
| Balances as of December 31, 2025 | 459 | $5 | 3 | $(225) | $6,707 | $5,281 | $— | $(1,388) | $11 | $10,390 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.